We have previously shown that sublytic heterologous complement induces large but transient increases in erythrocyte membrane permeability. We now report that when erythrocytes are bystanders in zymosan-activated autologous serum, they increase their Na+ permeability 1 0-fold, indicating that autologous complement can also induce transient membrane lesions. When w e isolated the effect of the C5b-9 membrane attack complex of complement by using human C5b-9 assembled from purified components, we found there was minimal lysis but efficient Na+ uptake.
Several specific plasma membrane proteins protect autologous cells from complement damage either by inhibiting complement activation or by preventing insertion of the MAC into the lipid bilayer.2 Nucleated cells can also repair a limited number of C5b-9 lesions3 by exocytotic shedding of the MAC in a membrane vesicle4 and by endocyto~is.~ It was unexpected that erythrocytes could also terminate nonlytic C5b-9 lesions. Evidence for this was provided by our previous studies of the membrane permeability of erythrocytes sensitized with antibodies and exposed to sublytic concentrations of heterologous serum as a source of complement. We found that uptake of Na' and glucose by unlysed cells increased several fold on complement activation but ceased before reaching isotopic equilibrium.6 These data provided functional proof of the transient nature of the sublytic complement lesion. Furthermore. we showed that in human erythrocytes, as Ca2+ leaks through the MAC, the Ca2+-activated K+ channel is recruited and the resulting net K+ efflux balances the cation content preventing colloidosmotic swelling of the 0 I993 by The American Society of Hematology.
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came lytic when extracellular Ca2+ was limited and when the cells were exposed to charybdotoxin, an inhibitor of the Ca2+-activated K' channel. This indicates that Ca2+ is required for the functional termination of the C5b-9 lesion. We also show that the membrane hyperpolarization resulting from activation of the Ca2+-dependent K+ efflux does not influence the termination of the C5b-9 lesion. Thus, the influx of Ca2+ through the complement lesion initiates at least two apparently independent adaptive responses: (1 ) a process that terminates the leak; and (2) a K+ efflux that has a volume regulatory function. Our data support the potential of the sublytic C5b-9 lesion to act as a physiologic mediator for autologous erythrocytes. targeted erythrocyte.' Recently, Iida et a1 have presented evidence indicating that erythrocytes can eliminate some C5b-9 lesions by Ca2+-dependent vesiculation and that an increased vesiculation is associated with a parallel decrease in
In this report we detail experiments that extend our previous observations to a homologous system, human erythrocytes and complement, and further define the compensatory mechanisms recruited by human erythrocytes under conditions that resemble complement activation in vivo. The membrane permeability to Na+, measured by the uptake of 22Na+, was used as a functional marker of all C5b-9 lesions. When human erythrocytes were exposed to zymosan-activated autologous serum, they experienced a large increase in their membrane permeability in the absence of any detectable cell lysis. To study further the kinetics of reversible C5b-9 homologous lesions we used purified human terminal complement components to eliminate any influence of membrane-bound antibody and complement fragments C4b and C3b. We found that external Ca2+ was essential for terminating the MAC-induced membrane leak and that a K+ efflux through the Ca2+-activated K+ channel' also contributed to the recovery of the target cells from homologous MAC lesions. The role of this K+ transport system as a protective mechanism against homologous complement damage seems to be limited to volume regulation because termination of the MAC does not require the efflux of K+ through the Ca2+-activated channel.
MATERIALS AND METHODS

Bufers and reagents.
Isotonic choline buffer consists of 150 mmol/L choline chloride, 1 mmol/L MgCl, and 10 mmol/L MOPSTris, pH 7.4. Gelatin-veronal buffer (GVB) is pH 7.4 isotonic veronalbuffered saline NaCl with 0.1% gelatin; GVB2+ is GVB with 0.15 mmol/L CaCI,, 0.5 mmol/L MgC12. GVB-EDTA is GVB with 0.5 mmol/L MgCI2 and I mmol/L EDTA buffered to pH 7.4. Charybdotoxin (Peptides International, Louisville, KY), dextran (molecular weight: 70,000) (Sigma Chemical Co, St Louis, MO), and zymosan (Sigma Chemical Co) were purchased.
Complement components/assays. Human erythrocytes were obtained from normal blood anticoagulated with EDTA and washed three times in EDTA buffer and twice in choline buffer. Human 20 1 erythrocytes were used the same day. Human serum was prepared from freshly clotted blood obtained from normal volunteers. Heated serum was incubated at 56°C for 30 minutes. C5b6 was madel' from purified C5, C6, factor B, and cobra venom factor (CVF), all purchased from Quidel (San Diego, CA), and recombinant mouse adipsin (factor D) (gift of T. White, Metabolic Biosystems, Mountain View, CA). Ni+ (1.0 mmol/L) was used to stabilize the CVFBb convertase." The C5b6 was fractionated by high performance liquid chromatography on a diethyl aminoethyl column (AP-1 Protein Pak 8HR Waters, Milford, MA). The reaction mixture was applied in buffer A (60 mmol/L NaCI, 10 mmol/L sodium phosphate buffer, pH 7.6) and eluted with a linear 60-minute gradient of buffer A and buffer B (500 mmol/L NaCI, 10 mmol/L sodium phosphate, pH 7.6). The C5b6 eluted as a distinct peak with a retention time of 39 to 40 minutes. The final C5b6 pool was about 100 pg/mL. In the experiment depicted (see Fig 6) , C5b6 was made as an eluate from zymosan that had been reacted with human serum.I2 Dilutions (0. I mL) of C5b6 were assayed using 0.1 mL human erythrocytes (1 X 108/mL), 0.1 mL purified C7 (1 pg/mL), and 0.1 mL of C8/9 (50 pg/mL of each) in GVBZ+ with reaction conditions specified by the supplier (Quidel).
One unit of C5b6 was defined as the amount necessary to yield a 2 of 1 .O as calculated from 2 = -I, [ 1 -y], where y equals the percent of cells hem01yzed.l~ The number of units in a C5b6 preparation was calculated from the reciprocal of the dilution that gave a 2 = 1 .O. The units used for a given experiment are specified in the respective figure legends. Of note, C5b6 was titered under the standard assay conditions in which the reactivity of C9 was not limited, whereas in the majority of experiments C5b6 was used under conditions where C9 reactivity was limited, effectively decreasing the functional titer of C5b6.
MACs were formed under conditions known to vary the amount of incorporated C9, as described.14 In brief, an EC5b-7 intermediate was made at 37°C by incubation of 0.1 mL human erythrocytes (1.1 X 108/mL) with 0.1 mL diluted C5b6 and 0. I mL C7 ( I pg/mL) for 20 minutes. The EC5b-7 intermediates were then chilled to 4°C before the addition of 10 pL C8/C9 mixture (50 pg/mL each) and further incubation for 1 hour at 4°C. Lesions with limited C9 were made by washing the cells free ofexcess C9 at 4°C before warming to 37°C. Lesions formed in the presence of an excess of C9 were made by directly warming up the mixture to 37°C.
One pCi/mL '*Na+ (specific activity 5 mCi/mg; Amersham, Arlington Heights, IL), was added to a prewarmed cell suspension in the corresponding medium (3 X IO8 cells/mL). At intervals thereafter aliquots were removed from the reaction mixtures, added to 10 mL of choline buffer and washed three times in the same buffer. The cells were lysed with Acationex (Sherwood Medical, St Louis, MO) 0.02% and duplicate aliquots of the supernatant were counted (cpm) in a y counter (Auto-Gamma 500, Packard Instrument Co, Lynn, MA). The amount of Na+ taken up by the cells at each time was calculated in millimoles/liter of cells from the counts per minute counted in the lysate, the concentration of hemoglobin determined (AU 540 nm) in each lysate, and the hematocrit and concentration of hemoglobin ofthe initial cell suspension as described.6
Measurement of "Na+ uptake.
RESULTS
A sublytic membrane lesion occurs in erythrocytes when serum complement is activated by zymosan. At zero time, zymosan (40 mg) was added to a IO-mL suspension ofwashed erythrocytes (1% hematocrit) in autologous serum that had been diluted one-third with GVB++ and contained 1 jtCi ' ' Na' . Zymosan was also added to a similar erythrocyte suspension made in heat-inactivated serum as control for the noncomplement-dependent uptake of "Na+ by the cells during the experiment. It was elected to use serum and not plasma for this experiment to avoid the effects of zymosan on platelets.
Zymosan activates complement primarily by the alternative pathway and leads to the generation of activated C5b6. C7 in the serum combines with C5b6 to form C5b67, some of which reacts with bystander cells, and can then react with serum C8 and C9 to form the MAC. Zymosan-activated fresh serum induced a rapid uptake of Na+ in the absence of any detectable cell lysis (Fig 1) . In contrast, addition of zymosan to heat-inactivated serum had a negligible effect on the basal Na+ uptake. The uptake represented a 10-fold increase of the Nat influx as compared with control (Fig 1 inset) . These results indicate that under conditions of autologous complement activation the erythrocytes can experience a nonlethal increase in membrane permeability comparable to that described by us with diluted heterologous serum.6 In both cases the lesion must be transient because it does not lead to cell lysis.
Effect of homologous MAC lesions formed in the presence of limited or excess C9. The size of the MAC and the diameter of its internal pore depends on the number of C9 molecules that bind to C5b-8: the lower the number of C9 molecules, the smaller the size of the ~0 r e . l~~~~
To investigate how the size of the complement lesion influences the kinetics of Na+ uptake by the target cells, we formed C9 lesions under conditions known to vary the number of C9 molecules in- For personal use only. on October 3, 2017. by guest www.bloodjournal.org From corporated into the MAC.I3 To test the methodology we first used activated human C5b6 and isolated human C7, 8, and 9, and sheep erythrocytes. The rate of lysis of sheep erythrocyte under conditions of limited C9 was gradual and linear with time; whereas under conditions of excess C9, lysis was more rapid and reached a plateau after x 10 minutes (Fig 2  inset) . Similar results had been described by Kim et al." When the same procedure was repeated using human erythrocytes as targets for activated human C5b-9, the lesion formed with limited C9 also led to a gradual, linear rate of lysis, whereas the presence of excess C9 caused a more rapid rate that reached a plateau after ru 10 minutes (Fig 2) .
Nu+ uptake and lysis induced by MAC lesions formed in the presence of limited C9. To assess the relationship between the change in membrane permeability and the induction of cell lysis by smaller C9 lesions, human erythrocytes were exposed to increasing doses of C5b6 at constant C7 and C8, and limited C9 concentrations. The MACs formed when C9 is limited induced a significant change in membrane permeability expressed as an increased Na+ leak in the absence of significant cell lysis (Fig 3) . Consistent with our results with heterologous complement, C5b-8 was sufficient to induce a reversible twofold increase in membrane permeability at the same relative concentrations of C5b6 and 7-9 that permitted a greater than IO-fold change in permeability (data not shown). by vesiculation depends on the availability of external Ca2+.4, 8 We wanted to investigate the broader issue of the effect of Ca2+ on permeability. Erythrocytes with MAC lesions made with limiting C9 were suspended in buffers of different concentrations of external Ca2+, and the permeability of the membrane was assessed following the kinetics of Na+ uptake. In the absence of Ca2+ (C$ = 0 mmol/L, EGTA 0.1 mmol/ L), the uptake of Na+ was much higher and prolonged than in the presence of Ca2+ (Fig 4) . No difference in the kinetics of Na+ uptake was detected between 0.125 and 1 mmol/L external Ca2+, indicating that the threshold level of Ca2+ to initiate the repair mechanism was exceeded at a concentration of Ca2+ far below the serum concentration of ionized Ca2+. These data confirm that a Ca2+ influx also modulates the termination of the functional complement lesion.
Termination of the MAC-induced Na+ leak depends on
Evidence for recruitment of the Ca2+-activated K+ channel by MACs made with limited C9. Human erythrocytes bearing C5b-7 complexes were prepared in GVB2+ and exposed to C8 and C9 in the presence of either 140 mmol/L NaCl or 140 mmol/L KCI, with all other components of the GVB2+ buffer kept constant. Lysis by homologous C9 lesions increased when the K+ concentration gradient was abolished by substitution of external Na+ by K+ (Fig 5) . Lysis also increased when Ca2+ was removed from the external medium and in the presence of charybdotoxin (20 nmol/L) (Fig 5) , an inhibitor of the Ca2+-activated K+ channel." Together, these experiments indicate that Ca2+-activated K+ efflux contributes to limit lysis mediated by homologous C9 MAC lesions.
Termination of the complement lesion and membrane potential. The high K+ conductance that results from the activation of the Ca2+-sensitive K+ channel can hyperpolarize the cell membrane, shifting Vm from the C1-equilibrium potential (b = -8 mV) toward the equilibrium potential
for K+.I9 To analyze the influence of membrane hyperpolarization on the kinetics of MAC-induced cation leak, the time course of Na+ influx into erythrocytes exposed to C5b-9 was compared in NaCl and in KCI buffers. To avoid the enhancement of colloidosmotic swelling and lysis that occurs when complement is activated in K+ rather than Na' medium, the experiments were performed in the presence of dextran (molecular weight 70,000,500 mg/mL). The kinetics of the Na+ leak induced by the MAC is independent of the presence of Na+ or K' in the external medium, indicating that the termination of the lesion does not depend on membrane hyperpolarization (Fig 6) .
DISCUSSION
Both erythrocytes and nucleated cells express several membrane proteins that restrict either complement activation or the assembly of the MAC, respxtively, and thereby protect host cells from complement-mediated lysis. However, it has been recognized that nucleated cells are much more resistant to complement lysis than erythrocytes.-' This resistance is attributed to the ability of the nucleated cell to shed MAC lesions from their membranes by either exocytosis or endocyto~is.~ We recently showed that erythrocytes can also recover from a complement attack and documented the transient nature of the sublytic complement lesion on heterologous cells.6.' The experiments in this report indicate that complement can also increase by several fold the membrane permeability of autologous cells in a manner that must be transient because it does not lead to cell lysis.
In the experiment described in Fig I , washed erythrocytes were immersed in autologous serum and complement was activated by the alternative pathway by addition of zymosan, conditions that mimic activation ofcomplement in vivo. Because the turnover rate of the Na+/K+/2CI-cotransport and Na+/H+ exchange, which mediate Na+ influx in erythrocytes, is very slow under the ionic conditions of this experiment:O the influx of Na' reflects the cation permeability of the membrane. The uptake of Na+ induced by zymosan-activated human serum persisted for at least 25 minutes (Fig I) . This differs significantly from the Na+ uptake induced by antibodyactivated heterologous complement, which terminated approximately IO minutes after the addition of complement! The discrepancy may reflect a longer duration of complement activation by zymosan or, alternatively, the transient MAC lesion could be modulated differently in the presence of heterologous as compared with autologous complement.
The MAC assembles on target cells first as a C5b-8 complex to which a varying number of C9 molecules then Poly C9 complexes exhibit the structure of hollow cylinders containing a central channel.ls Mono C9 lesions instead form functional but much smaller transmembrane pores that are not visible as cylindrical channel ~tructures.'~ We speculated that the kinetics of the permeability changes described in Fig  I could be related to the small size of the MACs induced by autologous serum. Under conditions of an excess of C9, lysis is faster and terminates earlier than when C9 is limited (Fig  2) . This phenomenon could be explained ifthe repair process terminating the MAC leak depended on a factor(s) that dif- fuses through the complement pore. The activation of this repair process would be influenced by the external concentration of the relevant factor and directly correlate with the size and/or permeability of the pore. Slow diffusion through the lesion formed with limited C9 would delay reaching the intracellular threshold concentration required to terminate the lesion.
We investigated the influence of external Ca2' on the kinetics of Na+ influx through the MAC. Reversal of the complement-induced changes in membrane permeability depends on the presence of external CaZ+, and the threshold for activation of the repair mechanism that functionally terminates the lesion is reached when external Ca2+ is at least 0.125 mmol/L. The kinetics of the MAC-induced Na+ leak in the presence of external Ca2+ is comparable to the time course of Ca2+-induced vesiculation shown by Iida et al,' indicating that vesiculation might be one mechanism used by erythrocytes to terminate the functional MACs. Whether other Ca2+-dependent mechanisms may contribute to reverse the increased membrane permeability is not known at present.
In view of our previous observation that the Ca2+ leak through the complement lesion recruits the erythrocyte Ca2+-activated K' channel: we have examined the possible contribution of this transport system to the termination of the functional complement lesion. First, we documented that the Ca2+-activated K+ channel is activated by homologous C5b-9 lesions. This conclusion is based on the finding that the substitution of Na+ for K+ in the external medium, the removal of Ca2' from the external medium, and the addition of charybdotoxin increase MAC-induced lysis (Fig 5) . These conditions: (1) abolish the chemical gradient for net K+ efflux; (2) remove the stimulus; and (3) selectively inhibit the Ca2'-activated K+ channel," respectively. Second, we explored the possible role of membrane hyperpolarization in the termination of the complement lesion. Because the C1-conductance of the erythrocyte membrane is orders of magnitude higher than the conductance for cations, it has been traditionally accepted that Vm always equals EC1. 22 However, we have shown that under some circumstances, which include the opening of the Ca2+-activated K+ channel, the cation conductance can be increased to a point that it shifts Vm toward Ecatians . I 9 Indeed, the addition of Ca2+ ionophore to human erythrocytes in the presence of external Ca2+ opens the Ca2+-activated K+ channel and shifts Vm from its resting value of -8 mV toward i~ -40 mV, a value closer to EK (data not shown). The steady-state value of Vm will depend on the relative conductance of the membrane for C1-and K' , according to the equation of Hodgkin and Huxleyl': Vm = t , -, . ECl + tK. EK, where t, represents the relative conductance of the xth ion. When external K+ is 140 mmol/L and EK = 0, opening of the IC+ conductance does not result in hyperpolarization of the membrane. Because no difference was detected when the kinetics of Na' influx induced by the MAC in NaCl medium was compared with that in KCI medium (Fig 6) , we conclude that hyperpolarization of the erythrocyte membrane does not seem to contribute to terminating these lesions. This was unexpected because hyperpolarization of the erythrocyte membrane has been shown to induce echinocyte f~rmation,'~ which is the first morphologic correlate noted in erythrocytes induced to vesiculate. 24- 26 The MAC has a clear role in the defense against microbes and tumor cells, and has also been associated with pathologic damage to autologous cells. With the recent appreciation of the nonlytic effects of complement mediated by transient and reversible changes in membrane permeability, the MAC assumes a new role as a potential physiological mediator. In vitro examples supporting this role of the MAC include its ability to activate platelets and to increase their procoagulant a~tivity,'~ to trigger protein kinase C,28329 and to stimulate the metabolism of arachidonic acid and its The data reported here, showing that complement activation comparable to that occumng in vivo can mediate significant transient changes in membrane permeability of autologous cells, further supports the concept of the MAC as a physiologic mediator. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
